Clinical Trials · NCT07424430
Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- LMC Diabetes & Endocrinology Ltd.
- Enrollment
- 3,392
- Start date
- Feb 2026
- Locations
- 1 site, Canada
- Primary endpoint
- Change in HbA1c- 3 Years